HPV+HNSCC harbors a low frequency of TP53 mutations and is associated with a relatively favorable prognosis comparing with that of TP53-mutated and/or CCND1-amplified HPV-HNSCC. Here, TP53 is linked to head and neck squamous cell carcinoma.